Harmony Medical Joined California Cardiovascular Accelerator
The Irish medical device firm will develop its cardiac stabilization technology within the US accelerator program.
Updated on Sept. 19, 2026 in Heart Disease
Live Poll
Should international accelerators prioritize including more medical start-ups from smaller countries?
Dublin-based Harmony Medical has been selected to join the Octane-Mussallem Cardiovascular Accelerator, becoming the only Irish firm in the current six-company cohort. The company is developing the Anchoring Sheath, a platform designed to provide stable access to the beating heart during cardiac procedures.
Why it matters
The accelerator provides essential access to US pediatric cardiac centers, clinicians, and investors to help refine specialized medical devices. Harmony Medical aims to use this partnership to reduce the reliance on open-heart surgery for pediatric patients.
Harmony Medical is developing the Anchoring Sheath, which has completed beating-heart proof-of-concept testing and secured a US patent. The firm is currently pursuing a De Novo submission to the FDA for its device.
The players
Harmony Medical
A Dublin-based medical device developer focused on cardiac access and stabilization technologies.
Octane
An innovation accelerator that has supported 2,500 companies and helped facilitate the creation of 45,000 jobs since 2010.
US Food and Drug Administration
The federal agency responsible for regulating medical devices and overseeing the approval processes for new clinical technologies.
Mussallem Foundation
A charitable organization that provides backing and support for the cardiovascular accelerator program.
The details
The Anchoring Sheath offers a controlled route for cardiac interventions, and the company has already received feedback from the US Food and Drug Administration. Through the program, Harmony Medical will leverage specialized mentorship and clinical connections to advance its commercialization strategy.
Timeline
The Octane innovation accelerator began supporting companies in 2010.
The company's selection was reported on September 19, 2026.
Health Landscape
The involvement of Harmony Medical in the Octane-Mussallem Cardiovascular Accelerator reflects a broader trend of international med-tech firms seeking integration into the US clinical infrastructure. This partnership structure accelerates the transition of devices from patent status to regulatory review.
Successful development of this technology could eventually provide pediatric patients with less invasive alternatives to traditional open-heart surgeries. The program aims to expedite these clinical pathways to ensure new stabilization tools reach hospital settings faster.
The takeaway
Advancements in cardiac stabilization platforms are critical for reducing the long-term physical toll of pediatric heart procedures. The integration of international firms into regional US accelerators represents a vital bridge between conceptual design and hospital adoption.
Further reading
Learn more about the latest innovations in Heart Disease management and surgical intervention.
Source note: This article includes information reported by Business Plus.
Live Poll
Should international accelerators prioritize including more medical start-ups from smaller countries?
